HDAC9 and cancer: We performed an iLINCS connected perturbations analysis, which included gene signatures from various cancer and cell models, and found that mivebresib treatment of UM cells causes a gene expression shift that is most similar to HDAC inhibitors (Fig. 4G; Supplementary Fig. 4G, I).